Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Selvita S.A - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Selvita S.A - Product Pipeline Review - 2014', provides an overview of the Selvita S.A's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Selvita S.A's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Selvita S.A including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Selvita S.A's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Selvita S.A's pipeline products Reasons to buy - Evaluate Selvita S.A's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Selvita S.A in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Selvita S.A's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Selvita S.A and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Selvita S.A - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Selvita S.A and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Selvita S.A Snapshot 5 Selvita S.A Overview 5 Key Information 5 Key Facts 5 Selvita S.A - Research and Development Overview 6 Key Therapeutic Areas 6 Selvita S.A - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Selvita S.A - Pipeline Products Glance 12 Selvita S.A - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Selvita S.A - Drug Profiles 14 SEL-103194 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 SEL-120 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 SEL-12034 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 SEL-141 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 SEL-24 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 SEL-24-A1 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 SEL-24-B 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 SEL24-B489 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 SLV-2436 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Drugs to Inhibit Heme Oxygenase-1 for Cancer 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Drugs to Inhibit Kinase for Cancer 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 SEL-128 Program 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 SEL-201 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 SEL-203 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 SEL-212 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 SEL-300 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Selvita S.A - Pipeline Analysis 31 Selvita S.A - Pipeline Products by Target 31 Selvita S.A - Pipeline Products by Route of Administration 33 Selvita S.A - Pipeline Products by Molecule Type 34 Selvita S.A - Pipeline Products by Mechanism of Action 35 Selvita S.A - Recent Pipeline Updates 37 Selvita S.A - Discontinued Pipeline Products 38 Discontinued Pipeline Product Profiles 38 SEL-103 38 Selvita S.A - Locations And Subsidiaries 39 Head Office 39 Appendix 40 Methodology 40 Coverage 40 Secondary Research 40 Primary Research 40 Expert Panel Validation 40 Contact Us 41 Disclaimer 41
List of Tables Selvita S.A, Key Information 5 Selvita S.A, Key Facts 5 Selvita S.A - Pipeline by Indication, 2014 8 Selvita S.A - Pipeline by Stage of Development, 2014 10 Selvita S.A - Monotherapy Products in Pipeline, 2014 11 Selvita S.A - Preclinical, 2014 12 Selvita S.A - Discovery, 2014 13 Selvita S.A - Pipeline by Target, 2014 32 Selvita S.A - Pipeline by Route of Administration, 2014 33 Selvita S.A - Pipeline by Molecule Type, 2014 34 Selvita S.A - Pipeline Products by Mechanism of Action, 2014 36 Selvita S.A - Recent Pipeline Updates, 2014 37 Selvita S.A - Discontinued Pipeline Products, 2014 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.